- Report
- June 2026
- 198 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- February 2026
- 250 Pages
Global
From €4067EUR$4,490USD£3,509GBP
- Report
- June 2026
- 372 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- November 2025
- 150 Pages
Global
From €3397EUR$3,750USD£2,931GBP
- Report
- January 2026
- 180 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 184 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 194 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- August 2025
- 193 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- February 2026
- 250 Pages
Global
From €4067EUR$4,490USD£3,509GBP
- Report
- June 2026
- 241 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- April 2026
- 115 Pages
Global
From €4302EUR$4,750USD£3,712GBP
- Report
- October 2025
- 160 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- September 2025
- 140 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- May 2026
- 142 Pages
Global
From €3622EUR$3,999USD£3,125GBP
- Report
- April 2026
- 148 Pages
Global
From €3622EUR$3,999USD£3,125GBP
- Report
- April 2026
- 140 Pages
Global
From €3622EUR$3,999USD£3,125GBP
- Report
- January 2026
- 184 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 180 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 194 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- June 2026
- 195 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP

The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more